Moses Huang Selected Research

Drug Therapy (Chemotherapy)

12/2017

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moses Huang Research Topics

Disease

12	Overactive Urinary Bladder (Overactive Bladder) 01/2019 - 09/2006
1	Lower Urinary Tract Symptoms 01/2019
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019
1	Urinary Retention 06/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Tachycardia (Tachyarrhythmias) 05/2017

Drug/Important Bio-Agent (IBA)

11	mirabegronIBA 01/2019 - 10/2014
9	Solifenacin Succinate FDA Link 01/2019 - 09/2006
4	Muscarinic AntagonistsIBA 01/2019 - 08/2015
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	TabletsIBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2017

Therapy/Procedure

3	Therapeutics 12/2017 - 01/2016
1	Drug Therapy (Chemotherapy) 12/2017
1	Bathroom Equipment 12/2017